Skip to main content
. 2014 Dec 31;5(24):12593–12606. doi: 10.18632/oncotarget.2518

Figure 1. Changes in genes expression from NBT to grade II and grade II to grade III astrocytomas.

Figure 1

(A) Differential genes were obtained from overlapping CGGA, GSE16011 and REMBRANDT databases. (B) A hematoxylin and eosin stained section was performed to determine the pathological type and grade and dysregulated genes were divided into up-regulated and down-regulated during malignant progression of astrocytomas. (C) KEEG pathways analysis performed using these differential expression genes on the DAVID website.